CNMD  Conmed Corporation




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+0.06 (+0.11%)

Growth Price

Overvalued by 27.71%

Stability Price

Overvalued by 67.19%

Company Metrics

  • 51.61 P/E
  • 2.1 P/S
  • 2.67 P/B
  • 1.08 EPS
  • 6.80% Cash ROIC
  • 0.57 Cash Ratio
  • 0.8 / 1.4% Dividend
  • 146,107.00 Avg. Vol.
  • 1.54B Market Cap.

Company Description

CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The company's products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery, and endoscopic technologies. It offers arthroscopy products, including powered resection instruments, art...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Stock in Focus - CONMED Corporation (NASDAQ:CNMD)
Vanguard Tribune - 1 hour ago
There are a number of sell-side research firms which cover CONMED Corporation (NASDAQ:CNMD) and offer projections on earnings and future stock movement.
Curt Hartman Named President and CEO of CONMED Corporation
GlobeNewswire (press release) - Nov 10, 2014
UTICA, N.Y., Nov. 10, 2014 (GLOBE NEWSWIRE) -- CONMED Corporation (Nasdaq:CNMD) today announced that its Board of Directors has appointed Curt Hartman as President and Chief Executive Officer, effective immediately.
CONMED Corporation Announces Leadership Transition
GlobeNewswire (press release) - Jul 23, 2014
UTICA, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- CONMED Corporation (Nasdaq:CNMD) today announced that Joseph Corasanti is stepping down as Chief Executive Officer, President and a member of the Board of Directors, effective immediately.
CONMED's (CNMD) CEO Curt Hartman on Q2 2014 Results - Earnings Call ... - Seeking Alpha
Executive shakeup at ConMed - Tampa Bay Business Journal
Stephen Mandia Unloaded $230715 Worth of CONMED Corporation (NASDAQ ... - May 6, 2015
CONMED Corporation (NASDAQ:CNMD) 55.31 -0.37 -0.66% director Stephen Mandia on the 06-05-2015 sold a total of 4,500 shares of the New York-based company valued at $230,715 US Dollars.
Director at Conmed Corp. is Selling Shares - Analyst Ratings
CONMED Rating Increased to Hold at Zacks (CNMD) - WKRB News
Stephen Mandia, director of CONMED Corporation (NASDAQ:CNMD) Just Sold ... - Apr 30, 2015
Stephen Mandia, the director of CONMED Corporation (NASDAQ:CNMD) 55.31 -0.37 -0.66% made insider sale of 3,899 shares with an average price per share of $50.0 in the New York-based Conmed Corp, that are having a value of $194,844 USD.
CONMED Director Stephen Mandia Sells 3899 Shares (CNMD) - WKRB News
CONMED Corporation to Announce First Quarter 2015 Financial Results on April ...
MarketWatch - Apr 7, 2015
UTICA, N.Y., Apr 07, 2015 (BUSINESS WIRE) -- CONMED Corporation CNMD, -2.96% today announced that it will report financial results for the first quarter of fiscal year 2015 after the market close on Wednesday, April 22, 2015.
CONMED Corporation (CNMD) Ex-Dividend Date Scheduled for March 12, 2015
Nasdaq - Mar 11, 2015
will begin trading ex-dividend on March 12, 2015. A cash dividend payment of $0.2 per share is scheduled to be paid on April 06, 2015.
CONMED Corporation Appoints Peter Shagory as Executive Vice President ...
OrthoSpineNews - May 12, 2015
UTICA, N.Y.–(BUSINESS WIRE)–May 11, 2015– CONMED Corporation (NASDAQ:CNMD) today announced that it has appointed Peter Shagory as the Company's Executive Vice President, Strategy and Corporate Development.
Sell-side Focus: CONMED Corporation (NASDAQ:CNMD)
Markets Daily - May 26, 2015
The consensus EPS estimate that analysts have on CONMED Corporation (NASDAQ:CNMD) for the quarter ending 2015-06-30 is $0.43.
Analyst Perspectives on CONMED Corporation (NASDAQ:CNMD)
Markets Daily - May 4, 2015
Based on analyst estimates, CONMED Corporation (NASDAQ:CNMD) is expected to post current fiscal quarter earnings per share of $0.43.
CONMED Shares Initiated With Buy At Deutsche Bank - Benzinga
CONMED Coverage Initiated at Deutsche Bank (CNMD) - The Legacy